Mother’s infarction (MFI) and Masif Fibrin Perive (MPFD) deposition (MPFD) are unusual, related to the condition of the secondary placenta of trophoblastic cell damage. The etiology is unknown but MPFD / MFI is associated with adverse obstetric results and a significant risk of repeatment. Case Report: We report the MPFD / MFI case related to placentitis Cytomegalovirus (CMV). A 27-year-old mother gave birth to a man’s fetus born with a postmortem diagnosis of default CMV.

The placenta shows limfohistiocial villitis with isolated CMV inclusion, in combination with MFI. Villitis has an intermediary feature between unclean cmv placentitis and ethiological villitis (Vue). Conclusion: Vue is considered a reaction of an anti-fetal immune mother who resembles the refusal of allograft. We postulate that viral infections in our case may have triggered this immune response, considering that CMV antigens are known to be crossing with some human antigens, especially HLA. The next trophoblastic cell damage can then lead to MFI / MFPD.

Hemolytic uremic syndrome and atypical nephrotic syndrome associated with cytomegalovirus infection

Atypical hemolytic uremic syndrome (ahus) is a rare disease. It is produced from the disregulation of alternative complementary pathways on the cell surface which causes endothelial damage. Increasing evidence evidence, this disorder is for mutations in the complementary regulator gene or with autoantibodies to complementary factors. This mutation has incomplete penetration and variable phenotypes.

Cytomegalovirus (CMV) is endemic throughout the world, and the incidence of severe CMV disease in immunocompetent adults seems to be greater than previously thought. Ahus and nephrotic syndrome associated with CMV infection rarely occur. The identification of triggers for the manifestation of the ahus in patients who are vulnerable genetics is very important because this allows faster clinical treatment and improvement initiations. We reported a case of a man with the removal of homozygous CFHR3-1 whose initial presentation was ahus and nephrotic syndrome associated with CMV infection.

IgA binds epitop glycoprotein B and neutralizes human cytomegalovirus

Human Cytomegalovirus (HCMV) is a pathogen everywhere that has the potential for pathogens in immunosuppression individuals and pregnant women during primary infections. HCMV Envelope Glycoprotein B (GB) facilitates virus entries into all types of cells and induces strong immune responses. Epitope AD-2 is a very preserved GB Linear GB epitope and the critical target for antibodies, only 50% of seropositive individuals that make IgG antibodies to this site and the rib response has not been fully investigated.

This study aims to compare IGG and IGA responses to GB and Epitop AD-2 in individuals who are exposed to naturally and those who receive the recombinant Ajuvant GB / MF59 vaccine. Thus, seropositive individual vaccination increases the existing IGA and GB IGG levels and induces the rib response and specific IGG de Novo GB on seronegative receivers. The existing IgG response and AD-2 ribs were driven by vaccination but the response of De Novo AD-2 was not detected. Individuals exposed naturally have the dominant IgG response to GB and AD-2 compared to weaker rib responses and variables, although significant rib response to AD-2 was observed in the ASI ASI sample.

All antibodies tie the AD-2 contain a light chain of kappa while the use of a balanced capa / lambda light chain is found for those who bind to GB. The V-region matches the specific recombinant IGG AD-2 and ribs are bound to GB and AD-2 and neutralize HCMV infection in vitro. Overall, this result shows that even though the human IGG response dominates, class IGA antibodies against AD-2 are significant components of breast milk that can function to protect neonates from HCMV.

Cytomegalovirus After a kidney transplant in 2020: moving towards personalized prevention

Cytomegalovirus (CMV) – Close complications after kidney transplants remain a substantial challenge. Instead of applying a preventive strategy to all risky patients, we can now adjust our strategies at the individual patient level. The prophylaxis of antivirus or strict pre-emptive strategies may be optimal for patients with the highest risk for CMV, while lower risk patients can be profitable especially from pre-emptive monitoring and therapeutic administration only if needed.

CMV Special T-Testing may be useful to improve the determination of CMV risk in pre-transplants, and to guide decisions about the need for antivirus therapy or duration. Immunosupressive regimens including the target of the Rapamycin mammal inhibitor reduces the risk of CMV and thus can be an interesting choice in some patients. The new antivirus agent further expanded our therapy arsenal in the near future, and the prospect of CMV vaccination and remove cell therapy seems to be on the horizon.

Cytomegalovirus Pre-Transplant Immunity and Risk of Viral Reactivation After Lung Transplantation: Prospective Cohort Study

Cytomegalovirus (CMV) remains a significant burden on the recipient of the lung transplant. Disadvantages in the immunity of the TP-transplant increases the risk of complications related to CMV. However, it is not clear if the underlying pre-transplant immunity increases risk. To assess this, we recruit 39 lung transplant patients and do quantiferon-CMV in their peripheral blood. More than a third of prospective cmv-seropositive transplant receivers are non-imun-reactive CMV (CMV-NIR) pre-transplant.

Hba Polyclonal Antibody
A53679	EpiGentek	100 µg	EUR 570.55
Description: The best epigenetics products

Anti-HBA antibody
STJ192419	St John's Laboratory	200 µl	EUR 197
Description: Unconjugated Rabbit polyclonal to HBA

HBA Polyclonal Antibody
ES11261-100ul	ELK Biotech	100ul	EUR 279
Description: A Rabbit Polyclonal antibody against HBA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

HBA Polyclonal Antibody
ES11261-50ul	ELK Biotech	50ul	EUR 207
Description: A Rabbit Polyclonal antibody against HBA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

Hba Antibody, HRP conjugated
1-CSB-PA010147LB01MO	Cusabio	EUR 317.00 EUR 335.00	100ug 50ug
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is HRP conjugated. Tested in the following application: ELISA

Hba Antibody, FITC conjugated
1-CSB-PA010147LC01MO	Cusabio	EUR 317.00 EUR 335.00	100ug 50ug
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is FITC conjugated. Tested in the following application: ELISA

Hba Antibody, Biotin conjugated
1-CSB-PA010147LD01MO	Cusabio	EUR 317.00 EUR 335.00	100ug 50ug
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is Biotin conjugated. Tested in the following application: ELISA

Human Brain Astrocytes (HBA)
HMP202	Neuromics	500,000+ cells - Frozen	EUR 1080

Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 2)
K6915803	ABM	1.0 ug DNA	EUR 154

Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 2)
K3179403	ABM	1.0 ug DNA	EUR 154

Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 2)
K3332403	ABM	1.0 ug DNA	EUR 154

Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 2)
K3266403	ABM	1.0 ug DNA	EUR 154

Mouse Hemoglobin subunit alpha (Hba)
1-CSB-YP010147MO	Cusabio	EUR 504.00 EUR 265.00 EUR 1832.00 EUR 763.00 EUR 1216.00 EUR 334.00	100ug 10ug 1MG 200ug 500ug 50ug
Description: Recombinant Mouse Hemoglobin subunit alpha(Hba) expressed in Yeast

Mouse Hemoglobin subunit alpha (Hba)
1-CSB-EP010147MO	Cusabio	EUR 505.00 EUR 265.00 EUR 1827.00 EUR 766.00 EUR 1218.00 EUR 335.00	100ug 10ug 1MG 200ug 500ug 50ug
Description: Recombinant Mouse Hemoglobin subunit alpha(Hba) expressed in E.coli

Hba-a2 Recombinant Protein (Rat)
RP204248	ABM	100 ug	Ask for price

Hba-a1 Recombinant Protein (Mouse)
RP140990	ABM	100 ug	Ask for price

Hba-a2 Recombinant Protein (Mouse)
RP140993	ABM	100 ug	Ask for price

Hba-x Recombinant Protein (Mouse)
RP140996	ABM	100 ug	Ask for price

Hemoglobin Subunit Alpha (Hba) Antibody
20-abx109857	Abbexa	EUR 411.00 EUR 1845.00 EUR 599.00 EUR 182.00 EUR 300.00	100 ug 1 mg 200 ug 20 ug 50 ug

Hba Polyclonal Antibody, HRP Conjugated
A53680	EpiGentek	100 µg	EUR 570.55
Description: kits suitable for this type of research

Hba Polyclonal Antibody, FITC Conjugated
A53681	EpiGentek	100 µg	EUR 570.55
Description: fast delivery possible

Hba Polyclonal Antibody, Biotin Conjugated
A53682	EpiGentek	100 µg	EUR 570.55
Description: reagents widely cited

HBA ELISA Kit (Bovine) (OKEH03848)
OKEH03848	Aviva Systems Biology	96 Wells	EUR 779
Description: Description of target: Involved in oxygen transport from the lung to the various peripheral tissues.;Species reactivity: Bovine;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.59 ng/mL

HBA ELISA Kit (Mouse) (OKEH05810)
OKEH05810	Aviva Systems Biology	96 Wells	EUR 662
Description: Description of target: Involved in oxygen transport from the lung to the various peripheral tissues. ;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.84 ng/mL

Rat Hemoglobin subunit alpha-1/2, HBA ELISA Kit
ELA-E0517r	Lifescience Market	96 Tests	EUR 886

Hba-a2 ORF Vector (Rat) (pORF)
ORF068084	ABM	1.0 ug DNA	EUR 506

Hba-a1 ORF Vector (Mouse) (pORF)
ORF046998	ABM	1.0 ug DNA	EUR 506

Hba-a2 ORF Vector (Mouse) (pORF)
ORF046999	ABM	1.0 ug DNA	EUR 506

Hba-x ORF Vector (Mouse) (pORF)
ORF047000	ABM	1.0 ug DNA	EUR 506

Human Anti-Influenza B virus IgA ELISA kit, 96 tests, Quantitative
920-410-HBA	Alpha Diagnostics	1 Kit	EUR 712

Human Hemoglobin subunit alpha, HBA ELISA Kit
ELA-E05171h	Lifescience Market	96 Tests	EUR 824

Bovine Hemoglobin subunit alpha, HBA ELISA Kit
ELA-E0517b	Lifescience Market	96 Tests	EUR 928

Chicken Hemoglobin subunit alpha, HBA ELISA Kit
ELA-E0517c	Lifescience Market	96 Tests	EUR 928

Canine Hemoglobin subunit alpha, HBA ELISA Kit
ELA-E0517d	Lifescience Market	96 Tests	EUR 928

Mouse Hemoglobin subunit alpha, HBA ELISA Kit
ELA-E0517m	Lifescience Market	96 Tests	EUR 865

Porcine Hemoglobin subunit alpha, HBA ELISA Kit
ELA-E0517p	Lifescience Market	96 Tests	EUR 928

Hba-a2 sgRNA CRISPR Lentivector set (Rat)
K6915801	ABM	3 x 1.0 ug	EUR 339

Hba-a2 sgRNA CRISPR Lentivector set (Mouse)
K3179401	ABM	3 x 1.0 ug	EUR 339

Hba-a1 sgRNA CRISPR Lentivector set (Mouse)
K3332401	ABM	3 x 1.0 ug	EUR 339

Hba-x sgRNA CRISPR Lentivector set (Mouse)
K3266401	ABM	3 x 1.0 ug	EUR 339

Bovine HBA/ Hemoglobin subunit alpha ELISA Kit
E0304Bo	Sunlong	1 Kit	EUR 717

2-Propyl-β-D-glucuronide, 2 mg
0904-2	AthenaES	2 mg	EUR 162

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
K6915807	ABM	1.0 ug DNA	EUR 167

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
K3179407	ABM	1.0 ug DNA	EUR 167

Hba-a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
K3332407	ABM	1.0 ug DNA	EUR 167

Hba-x sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
K3266407	ABM	1.0 ug DNA	EUR 167

IL-2 Interleukin-2 Human Recombinant Protein, His Tag
PROTP60568-2	BosterBio	Regular: 10ug	EUR 317
Description: Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 133 amino acids fragment (21-153) having a molecular weight of 20kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. _x000D_ The IL-2 His is purified by proprietary chromatographic techniques._x000D_

BMP-2 Bone Morphogenetic Protein-2 Human Recombinant Protein, Monomer
PROTP12643-2	BosterBio	Regular: 20ug	EUR 317
Description: Bone Morphogenetic Protein-2 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, Polypeptide chain containing 115 amino acids (283-396) and having a molecular mass of 13009 Dalton. ;The BMP-2 is purified by proprietary chromatographic techniques.

Individual Reaction Mix 2
G065-2	ABM	200 reactions	EUR 167

PG LIVER 2 EA*
59423-2	Pel-Freez	2 EA	EUR 192.24

Hba-a1 3'UTR Luciferase Stable Cell Line
TU109375	ABM	1.0 ml	Ask for price

Hba-a2 3'UTR Luciferase Stable Cell Line
TU109376	ABM	1.0 ml	Ask for price

Hba-x 3'UTR Luciferase Stable Cell Line
TU109377	ABM	1.0 ml	Ask for price

Hba-a2 3'UTR Luciferase Stable Cell Line
TU205653	ABM	1.0 ml	Ask for price

Hba-a1 3'UTR GFP Stable Cell Line
TU159375	ABM	1.0 ml	Ask for price

Hba-a2 3'UTR GFP Stable Cell Line
TU159376	ABM	1.0 ml	Ask for price

Hba-x 3'UTR GFP Stable Cell Line
TU159377	ABM	1.0 ml	Ask for price

Hba-a2 3'UTR GFP Stable Cell Line
TU255653	ABM	1.0 ml	Ask for price

Hba-a2 Protein Vector (Rat) (pPB-C-His)
PV272334	ABM	500 ng	EUR 603

Hba-a2 Protein Vector (Rat) (pPB-N-His)
PV272335	ABM	500 ng	EUR 603

Hba-a2 Protein Vector (Rat) (pPM-C-HA)
PV272336	ABM	500 ng	EUR 603

Hba-a2 Protein Vector (Rat) (pPM-C-His)
PV272337	ABM	500 ng	EUR 603

Hba-a1 Protein Vector (Mouse) (pPB-C-His)
PV187990	ABM	500 ng	EUR 603

Hba-a1 Protein Vector (Mouse) (pPB-N-His)
PV187991	ABM	500 ng	EUR 603

Hba-a1 Protein Vector (Mouse) (pPM-C-HA)
PV187992	ABM	500 ng	EUR 603

Hba-a1 Protein Vector (Mouse) (pPM-C-His)
PV187993	ABM	500 ng	EUR 603

Hba-a2 Protein Vector (Mouse) (pPB-C-His)
PV187994	ABM	500 ng	EUR 603

Hba-a2 Protein Vector (Mouse) (pPB-N-His)
PV187995	ABM	500 ng	EUR 603

Hba-a2 Protein Vector (Mouse) (pPM-C-HA)
PV187996	ABM	500 ng	EUR 603

Hba-a2 Protein Vector (Mouse) (pPM-C-His)
PV187997	ABM	500 ng	EUR 603

Hba-x Protein Vector (Mouse) (pPB-C-His)
PV187998	ABM	500 ng	EUR 603

Hba-x Protein Vector (Mouse) (pPB-N-His)
PV187999	ABM	500 ng	EUR 603

Hba-x Protein Vector (Mouse) (pPM-C-HA)
PV188000	ABM	500 ng	EUR 603

Hba-x Protein Vector (Mouse) (pPM-C-His)
PV188001	ABM	500 ng	EUR 603

Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 1)
K6915802	ABM	1.0 ug DNA	EUR 154

Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 3)
K6915804	ABM	1.0 ug DNA	EUR 154

Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K3179402	ABM	1.0 ug DNA	EUR 154

Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K3179404	ABM	1.0 ug DNA	EUR 154

Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K3332402	ABM	1.0 ug DNA	EUR 154

Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K3332404	ABM	1.0 ug DNA	EUR 154

Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 1)
K3266402	ABM	1.0 ug DNA	EUR 154

Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 3)
K3266404	ABM	1.0 ug DNA	EUR 154

pLenti-CARM1 shRNA-2 Plasmid
PVTBAV03691-2	Lifescience Market	2 ug	EUR 356

pLenti-CTLA4 shRNA-2 Plasmid
PVTBAV05689-2	Lifescience Market	2 ug	EUR 356

pLenti-FOXM1 shRNA-2 Plasmid
PVTBAV08732-2	Lifescience Market	2 ug	EUR 356

pLenti-JUN shRNA-2 Plasmid
PVTBAV11741-2	Lifescience Market	2 ug	EUR 356

pLenti-LHX6 shRNA-2 Plasmid
PVTBAV12881-2	Lifescience Market	2 ug	EUR 356

pLenti-MAGEA3 shRNA-2 Plasmid
PVTBAV13661-2	Lifescience Market	2 ug	EUR 356

pLenti-RUNX3 shRNA-2 Plasmid
PVTBAV20583-2	Lifescience Market	2 ug	EUR 356

pLenti-Slc7a11 shRNA-2 Plasmid
PVTBAV21973-2	Lifescience Market	2 ug	EUR 356

pLenti-STAT3 shRNA-2 Plasmid
PVTBAV22921-2	Lifescience Market	2 ug	EUR 356

pLenti-XRCC5 shRNA-2 Plasmid
PVTBAV26238-2	Lifescience Market	2 ug	EUR 356

Dr. P Kit-Solution 2
K2021010-2	Biochain	6 ml	EUR 120
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Anti-ErbB 2/ERBB2 Antibody
A00010-2	BosterBio	100ug/vial	EUR 334

Anti-Bcl-2/BCL2 Antibody
A00040-2	BosterBio	100ug/vial	EUR 334

Anti-Angiopoietin-2/ANGPT2 Antibody
A00370-2	BosterBio	100ug/vial	EUR 334

Anti-EIF4A1/2/3 Antibody
A03922-2	BosterBio	100ug/vial	EUR 334

Anti-Fascin 2/FSCN2 Antibody
A07840-2	BosterBio	100ug/vial	EUR 294

Bovine KIDNEY WHOLE 2 EA*
57120-2	Pel-Freez	2 EA	EUR 174.84

Recombinant Human TFF-2 Protein
PROTQ03403-2	BosterBio	20ug	EUR 317
Description: The Trefoil Factor peptides (TFF1, TFF2 and TFF3) are expressed in the gastrointestinal tract, and appear to play an important role in intestinal mucosal defense and repair. TFF2 has been shown to inhibit gastrointestinal motility and gastric acid secretion. Recent data suggests a potential role for TFF2 in acute and chronic asthma (Nikolaidis, N.M. et al. Am. Journal Respir. Cell Mol. Biol. (2003) 4: 458-464). Recombinant human TFF2 is a 12.0 kDa polypeptide of 107 amino acid residues, which includes a 40-amino acid trefoil motif containing three conserved intramolecular disulfide bonds.

Recombinant Human Relaxin-2 Protein
PROTP04090-2	BosterBio	25ug	EUR 317
Description: Relaxin-2 is a peptide hormone structurally related to insulin, which is expressed in the placenta, decidua, prostate, and in the ovary during pregnancy. Of the three known relaxin genes, Relaxin-2 is the only relaxin known to circulate in the blood. Relaxin-2 binds specifically to the LGR7 and LGR8 receptors, previously identified as an “orphan” G protein coupled receptors. Signaling by Relaxin-2 through its target receptors enhances the growth of pubic ligaments and ripening of the cervix during birth. Recombinant Relaxin-2 is a nonglycosylated 6.0 kDa disulfide linked heterodimeric protein consisting of a 24 amino acid A-chain and a 29 amino acid B-chain.

Recombinant Murine IL-2 Protein
PROTP04351-2	BosterBio	20ug	EUR 317
Description: IL-2 is a powerful immunoregulatory lymphokine produced by T-cells in response to antigenic or mitogenic stimulation. IL-2/IL-2R signaling is required for T-cell proliferation and other fundamental functions which are essential for the immune response. IL-2 stimulates growth and differentiation of B-cells, NK cells, lymphokine activated killer cells, monocytes, macrophages and oligodendrocytes. Recombinant murine IL-2 is a 17.2 kDa protein, containing 149 amino acid residues.

Recombinant Human PAI-2 Protein
PROTP05120-2	BosterBio	10ug	EUR 317
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein.

Recombinant Human MMP-2 Protein
PROTP08253-2	BosterBio	10ug	EUR 317
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-2 is a secreted collagenase with specificity toward Type IV, V, VII, and X collagens. Recombinant human MMP-2 is a 62.0 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (552 amino acids).

Mouse FGF-2 Recombinant Protein
R00121-2	BosterBio	5ug/vial	EUR 259
Description: FGF basic (FGF2) is a multipotential fibroblast growth factor that stimulates and supports proliferation, migration and differentiation. Mouse FGF basic (FGF-2) Recombinant Protein is purified FGF basic (FGF-2) produced in yeast.

Chicken IL-2 Recombinant Protein
R00387-2	BosterBio	5ug/vial	EUR 259
Description: Interleukin-2 (IL-2) is a cytokine produced by T-helper cells in response to antigenic or mitogenic stimulation. It is required for T-cell proliferation and other activities crucial to the regulation of the immune response. Chicken IL-2 Recombinant Protein is purified interleukin-2 produced in yeast.

Recombinant Human BD-2 Protein
PROTO15263-2	BosterBio	20ug	EUR 317
Description: Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The α-defensins are distinguished from the β-defensins by the pairing of their three disulfide bonds. To date, six human β-defensins have been identified; BD-1, BD-2, BD-3, BD-4, BD-5 and BD-6. β-defensins are expressed on some leukocytes and at epithelial surfaces. In addition to their direct antimicrobial activities, they can act as chemoattractants towards immature dendritic cells and memory T cells. The β-defensin proteins are expressed as the C-terminal portion of precursors and are released by proteolytic cleavage of a signal sequence and in some cases, a propeptide sequence. β-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds. Recombinant human BD-2 is a 4.3 kDa protein containing 41 amino acid residues.

Ethyl-β-D-glucuronide, 2 mg
0901-2	AthenaES	2 mg	EUR 162

Ethyl sulfate, sodium salt, 2 mg
0902-2	AthenaES	2 mg	EUR 69

Propyl-β-D-glucuronide, 2 mg
0903-2	AthenaES	2 mg	EUR 162

Anti-COX2/Cyclooxygenase 2/PTGS2 Antibody
A00084-2	BosterBio	100ug/vial	EUR 294

The CMV-NIR status is associated with the incidence of CMV reactivation transplantation which is significantly higher, indicating that the immunity of CMV dysfunctional in prospective lung transplant recipients is associated with an increased risk of viral viral-transplant reactivation.
Keywords: cytomegalovirus; T-cell immunity; solid organ transplant; Virus reactivation.